Cargando…

Interactions of melatonin with various signaling pathways: implications for cancer therapy

Melatonin is a neuro-hormone with conserved roles in evolution. Initially synthetized as an antioxidant molecule, it has gained prominence as a key molecule in the regulation of the circadian rhythm. Melatonin exerts its effect by binding to cytoplasmic and intra-nuclear receptors, and is able to re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mihanfar, Ainaz, Yousefi, Bahman, Azizzadeh, Bita, Majidinia, Maryam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798601/ https://www.ncbi.nlm.nih.gov/pubmed/36581900 http://dx.doi.org/10.1186/s12935-022-02825-2

Ejemplares similares

Nanotechnology-based advances in the efficient delivery of melatonin
por: Mirza-Aghazadeh-Attari, Mohammad, et al.
Publicado: (2022)

Melatonin increases 5-flurouracil-mediated apoptosis of colorectal cancer cells through enhancing oxidative stress and downregulating survivin and XIAP
por: Mihanfar, Ainaz, et al.
Publicado: (2021)

Effects of Ramadan Fasting on Serum Amyloid A and Protein Carbonyl Group Levels in Patients With Cardiovascular Diseases
por: Asadi, Hami, et al.
Publicado: (2015)

Molecular Targeting of Notch Signaling Pathway by DAPT in Human Ovarian Cancer: Possible Anti Metastatic Effects
por: Akbarzadeh, Maryam, et al.
Publicado: (2018)

Role and Therapeutic Potential of Melatonin in Various Type of Cancers
por: Gurunathan, Sangiliyandi, et al.
Publicado: (2021)

Targeting microRNAs with thymoquinone: a new approach for cancer therapy
por: Homayoonfal, Mina, et al.
Publicado: (2021)

Melatonin and non-small cell lung cancer: new insights into signaling pathways
por: Pourhanifeh, Mohammad Hossein, et al.
Publicado: (2019)

Melatonin Signaling Pathways Implicated in Metabolic Processes in Human Granulosa Cells (KGN)
por: Asma, Arjoune, et al.
Publicado: (2022)

Breast Cancer Stem Cells: Signaling Pathways, Cellular Interactions, and Therapeutic Implications
por: Wang, Lei, et al.
Publicado: (2022)

Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer
por: Zeng, Zhen, et al.
Publicado: (2023)

Curcumin anti‐tumor effects on endometrial cancer with focus on its molecular targets
por: Jahanbakhshi, Fahime, et al.
Publicado: (2021)

Potential Therapeutic Targets of Quercetin, a Plant Flavonol, and Its Role in the Therapy of Various Types of Cancer through the Modulation of Various Cell Signaling Pathways
por: Almatroodi, Saleh A., et al.
Publicado: (2021)

FGF/FGFR signaling pathway involved resistance in various cancer types
por: Zhou, Yangyang, et al.
Publicado: (2020)

Anti-tumor activities of probiotics in cervical cancer
por: Jahanshahi, Moghaddaseh, et al.
Publicado: (2020)

Key Genes in the Melatonin Biosynthesis Pathway with Circadian Rhythm Are Associated with Various Abiotic Stresses
por: Ahn, Hye-Ryun, et al.
Publicado: (2021)

Signaling pathways in rheumatoid arthritis: implications for targeted therapy
por: Ding, Qian, et al.
Publicado: (2023)

DNA repair and damage pathways in mesothelioma development and therapy
por: Malakoti, Faezeh, et al.
Publicado: (2022)

Signaling Pathways in Thyroid Cancer and Their Therapeutic Implications
por: Jin, Shan, et al.
Publicado: (2016)

Oleanolic Acid Alters Multiple Cell Signaling Pathways: Implication in Cancer Prevention and Therapy
por: Žiberna, Lovro, et al.
Publicado: (2017)

Melatonin and Pathological Cell Interactions: Mitochondrial Glucose Processing in Cancer Cells
por: Reiter, Russel J., et al.
Publicado: (2021)

Potential of Melatonin as Adjuvant Therapy of Oral Cancer in the Era of Epigenomics
por: Capote-Moreno, Ana, et al.
Publicado: (2019)

Melatonin Therapy in Patients with Alzheimer’s Disease
por: Cardinali, Daniel P., et al.
Publicado: (2014)

Natural products, PGC-1α, and Duchenne muscular dystrophy
por: Suntar, Ipek, et al.
Publicado: (2020)

Melatonin and Cancer Hallmarks
por: Talib, Wamidh H.
Publicado: (2018)

Clinical Implications of Hedgehog Pathway Signaling in Prostate Cancer
por: Suzman, Daniel L., et al.
Publicado: (2015)

Melatonin Inhibits Osteoclastogenesis and Osteolytic Bone Metastasis: Implications for Osteoporosis
por: MacDonald, Iona J., et al.
Publicado: (2021)

The Hippo signaling pathway in leukemia: function, interaction, and carcinogenesis
por: Noorbakhsh, Negar, et al.
Publicado: (2021)

Melatonin Mitigates Mitochondrial Meltdown: Interactions with SIRT3
por: Reiter, Russel J., et al.
Publicado: (2018)

Context-dependent signal integration by the GLI code: The oncogenic load, pathways, modifiers and implications for cancer therapy
por: Aberger, Fritz, et al.
Publicado: (2014)

Melatonin and 5-fluorouracil combination chemotherapy: opportunities and efficacy in cancer therapy
por: Mafi, Alireza, et al.
Publicado: (2023)

Anti-cancer properties of quercetin in osteosarcoma
por: Maleki Dana, Parisa, et al.
Publicado: (2021)

Cooperative integration between HEDGEHOG-GLI signalling and other oncogenic pathways: implications for cancer therapy
por: Pandolfi, Silvia, et al.
Publicado: (2015)

The intersection of COVID-19 and cancer: signaling pathways and treatment implications
por: Zong, Zhi, et al.
Publicado: (2021)

Circular RNAs: implications of signaling pathways and bioinformatics in human cancer
por: Hu, Fan, et al.
Publicado: (2023)

S-nitrosylation in TNF superfamily signaling pathway: Implication in cancer()
por: Plenchette, Stéphanie, et al.
Publicado: (2015)

mTOR signaling: implications for cancer and anticancer therapy
por: Petroulakis, E, et al.
Publicado: (2006)

Epigenetic Regulation of TRAIL Signaling: Implication for Cancer Therapy
por: Elmallah, Mohammed I. Y., et al.
Publicado: (2019)

Melatonin for the prevention and treatment of cancer
por: Li, Ya, et al.
Publicado: (2017)

Exosomes and COVID-19: challenges and opportunities
por: Babaei, Ghader, et al.
Publicado: (2022)

Characterization of the various functional pathways elicited by synthetic agonists or antagonists at the melatonin MT(1) and MT(2) receptors
por: Legros, Céline, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fbio8jauku16jrcf8q131qdbdu